HTRA3 antibody (AA 330-362)

Catalog No. ABIN5647345

The Rabbit Polyclonal anti-HTRA3 antibody is suitable to detect HTRA3 in samples from Human. It has been validated for WB.

Quick Overview for HTRA3 antibody (AA 330-362) (ABIN5647345)

Target: HTRA3 (HtrA Serine Peptidase 3 (HTRA3))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This HTRA3 antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-HTRA3 Antibody

Binding Specificity: AA 330-362

Purpose: HtrA3 Antibody

Sequence: FAIPSDRITR FLTEFQDKQI KDWKKRFIGI RMR

Purification: Antigen affinity

Immunogen: Amino acids 330-362 (FAIPSDRITRFLTEFQDKQIKDWKKRFIGIRMR) from the human protein were used as the immunogen for the HtrA3 antibody.

Isotype: IgG

Application Details

Application Notes: Optimal dilution of the HtrA3 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Storage: 4 °C,-20 °C

Storage Comment: After reconstitution, the HtrA3 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Target Details for HTRA3

Target: HTRA3 (HtrA Serine Peptidase 3 (HTRA3))

Alternative Name: HtrA3

Background: Human HtrA3 protease, which induces mitochondria-mediated apoptosis, can be a tumor suppressor and a potential therapeutic target in the treatment of cancer. It may also have a role in ovarian development, granulosa cell differentiation and luteinization. The long isoform, HTRA3L, contains 453 amino acids and has a predicted molecular mass of 49 kD. It contains an N-terminal signal peptide, followed by an insulin/IGF (see 147440)-binding domain, a Kazal-type S protease inhibitor domain, a trypsin protease domain, and a PDZ domain. The short isoform, HTRA3S, contains 357 amino acids and has a predicted molecular mass of 38 kD.

UniProt: P83110